≡

Ring Finger Protein 55 (RNF55)

[Edit]

CBL; C-CBL; CBL2; Cas-Br-M(Murine)Ecotropic Retroviral Transforming Sequence; Casitas B-lineage Lymphoma; Proto-oncogene c-Cbl; Signal transduction protein CBL

Ring Finger Protein 55 (RNF55)
CCC E942
HGNC 1541
MGI 88279
PubMed 21422499
RGD 1561386
UniProt P22681
Wiki RNF55
The virus used in the experiment was a retrovirus known as Cas-Br-M, and was found to have excised approximately a third of the original c-Cbl gene from mice it was injected into. Sequencing revealed that the portion carried by the retrovirus encoded a tyrosine kinase binding domain, and that this was the oncogenic form as retroviruses carrying full-length c-Cbl did not induce tumour formation. The resultant transformed retrovirus was found to consistently induce a type of pre-B lymphoma, known as Casitas B-lineage lymphoma, in infected mice.
This domain structure and the tyrosine and serine-rich content of the protein product is typical of an "adaptor molecule" used in cell signalling pathways.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPE942Hu01 Recombinant Ring Finger Protein 55 (RNF55) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAE942Hu01 Polyclonal Antibody to Ring Finger Protein 55 (RNF55) WB; IHC; ICC; IP.
Assay Kits SEE942Hu ELISA Kit for Ring Finger Protein 55 (RNF55) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Ring Finger Protein 55 (RNF55) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Ring Finger Protein 55 (RNF55) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Ring Finger Protein 55 (RNF55) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Ring Finger Protein 55 (RNF55) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ring Finger Protein 55 (RNF55) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Ring Finger Protein 55 (RNF55) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Ring Finger Protein 55 (RNF55) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Ring Finger Protein 55 (RNF55) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Ring Finger Protein 55 (RNF55) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ring Finger Protein 55 (RNF55) ELISA Kit Customized Service Offer
  1. "The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif."Oncogene 6:653-657(1991) [PubMed] [Europe PMC] [Abstract]
  2. "Human chromosome 11 DNA sequence and analysis including novel gene identification." Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase."Biochem. Biophys. Res. Commun. 257:129-138(1999) [PubMed] [Europe PMC] [Abstract]
  5. "The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase."Science 286:309-312(1999) [PubMed] [Europe PMC] [Abstract]
  6. "The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor."J. Biol. Chem. 269:22921-22924(1994) [PubMed] [Europe PMC] [Abstract]
  7. "Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation."J. Biol. Chem. 270:20242-20245(1995) [PubMed] [Europe PMC] [Abstract]
  8. "The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70."J. Biol. Chem. 272:33140-33144(1997) [PubMed] [Europe PMC] [Abstract]
  9. "Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases."J. Biol. Chem. 273:8867-8874(1998) [PubMed] [Europe PMC] [Abstract]
  10. "Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling."J. Exp. Med. 196:1617-1626(2002) [PubMed] [Europe PMC] [Abstract]
  11. "C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus."Oncogene 21:1079-1089(2002) [PubMed] [Europe PMC] [Abstract]
  12. "Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation."Oncogene 21:1707-1716(2002) [PubMed] [Europe PMC] [Abstract]
  13. "Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils."Biochem. J. 370:687-694(2003) [PubMed] [Europe PMC] [Abstract]
  14. "APS, an adaptor protein containing pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl."Leukemia 13:760-767(1999) [PubMed] [Europe PMC] [Abstract]
  15. "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis."Oncogene 18:759-767(1999) [PubMed] [Europe PMC] [Abstract]
  16. "SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling."Proc. Natl. Acad. Sci. U.S.A. 96:9775-9780(1999) [PubMed] [Europe PMC] [Abstract]
  17. "Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling." J. Exp. Med. 194:1263-1276(2001) [PubMed] [Europe PMC] [Abstract]
  18. "The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction."J. Biol. Chem. 276:4957-4963(2001) [PubMed] [Europe PMC] [Abstract]
  19. "APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes."Mol. Cell. Biol. 22:3599-3609(2002) [PubMed] [Europe PMC] [Abstract]
  20. "The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2."Biochem. Biophys. Res. Commun. 300:494-500(2003) [PubMed] [Europe PMC] [Abstract]
  21. "Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry."Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003) [PubMed] [Europe PMC] [Abstract]
  22. "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry."Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract]
  23. "Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation."Oncogene 23:1645-1655(2004) [PubMed] [Europe PMC] [Abstract]
  24. "Signal transduction via the stem cell factor receptor/c-Kit."Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed] [Europe PMC] [Abstract]
  25. "Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl."FEBS Lett. 577:555-562(2004) [PubMed] [Europe PMC] [Abstract]
  26. "Src kinase activity is essential for osteoclast function."J. Biol. Chem. 279:17660-17666(2004) [PubMed] [Europe PMC] [Abstract]
  27. "Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation."J. Biol. Chem. 279:36259-36267(2004) [PubMed] [Europe PMC] [Abstract]
  28. "ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth."J. Cell Sci. 117:3319-3329(2004) [PubMed] [Europe PMC] [Abstract]
  29. "Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation."Biochem. Biophys. Res. Commun. 333:180-185(2005) [PubMed] [Europe PMC] [Abstract]
  30. "Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor."Biochem. Biophys. Res. Commun. 337:1-13(2005) [PubMed] [Europe PMC] [Abstract]
  31. "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract]
  32. "A probability-based approach for high-throughput protein phosphorylation analysis and site localization."Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract]
  33. "The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor."FEBS J. 274:3078-3093(2007) [PubMed] [Europe PMC] [Abstract]
  34. "Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation."J. Biol. Chem. 282:29336-29347(2007) [PubMed] [Europe PMC] [Abstract]
  35. "Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells."Blood 111:3821-3829(2008) [PubMed] [Europe PMC] [Abstract]
  36. "FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival."Bone 42:1032-1039(2008) [PubMed] [Europe PMC] [Abstract]
  37. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  38. "Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway."Traffic 9:251-266(2008) [PubMed] [Europe PMC] [Abstract]
  39. "Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation."Biochem. J. 423:375-380(2009) [PubMed] [Europe PMC] [Abstract]
  40. "An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis."Curr. Biol. 19:1788-1798(2009) [PubMed] [Europe PMC] [Abstract]
  41. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  42. "Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration."Cell. Signal. 22:1363-1368(2010) [PubMed] [Europe PMC] [Abstract]
  43. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  44. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  45. "The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination."J. Biol. Chem. 286:24443-24450(2011) [PubMed] [Europe PMC] [Abstract]
  46. "Fibroblast growth factor signalling: from development to cancer."Nat. Rev. Cancer 10:116-129(2010) [PubMed] [Europe PMC] [Abstract]
  47. "Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase."Nature 398:84-90(1999) [PubMed] [Europe PMC] [Abstract]
  48. "Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases."Cell 102:533-539(2000) [PubMed] [Europe PMC] [Abstract]
  49. "Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype." Am. J. Hum. Genet. 87:250-257(2010) [PubMed] [Europe PMC] [Abstract]
  50. "Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism."J. Biol. Chem. 285:32596-32605(2010) [PubMed] [Europe PMC] [Abstract]